Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy Genetics Investing
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018 Genetics Investing
Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update Genetics Investing
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018 Medical Device Investing
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma Pharmaceutical Investing